“…Here, the importance of integrated assessments has been underlined by von Schomberg [7], while a related care for the future impact of new and emerging technologies has been voiced by Owen, et al [8]. Relevant to my argument is the demonstration by Fitzgerald and Adam [9] of the fragmentary decision-making landscape in Europe for assistive technologies, the lax and seemingly arbitrary approaches to testing of assistive technologies [10,11], and the recent report from the European Parliamentary Research Service Scientific Foresight Unit (STOA) voicing concerns over lack of proper assessments of assistive technologies classified as consumer technologies, which constitute the large majority of the marketed products [12]. Hopefully, my contribution might serve as a first brick in a bridge between the hasty, short-spanned, and profit-based logic in industry and the careful, person-centered, and budget-based logics of the health sector, as proposed by Demers-Payette, et al [13], through the use of similar assessment instruments.…”